Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia

Clinical trial NCT03802201 · COMPLETED

Trial details

NCT number: NCT03802201
Sponsor: Protagonist Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

β-thalassemia Ineffective Erythropoiesis Chronic Anemia

Start date: 2018-12-19
Primary completion: 2020-07-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.